PharmTech

Integrating AI and Machine Learning in Drug Discovery and Development

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
SiliconANGLE

Machine learning in drug discovery speeds up development

Machine learning in drug discovery, along with artificial intelligence, is transforming the pharmaceutical industry by accelerating the development of new treatments. Historically, the process of ...

Antibody Discovery Market to Hit USD 35.35 Billion by 2035, Driven by AI and Technology Innovations

The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...
MobiHealthNews

AI researcher Daphne Koller heading new machine learning drug discovery venture

In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing ...

Soley Therapeutics Announces Breakthrough Research Demonstrating How Cellular Stress Responses Reveal Drug Mechanisms, Enabling Entirely New and Accelerated Methods for Drug ...

Soley Announces Breakthrough Research Demonstrating How Cellular Stress Responses Reveal Drug Mechanisms, Enabling New Methods for Drug Discovery ...
National Academies of Sciences%2c Engineering%2c and Medicine

Accelerating Drug Discovery with Machine Learning

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Drug Target Review

insitro expands AI drug discovery with CombinAbleAI acquisition

insitro has acquired Israeli AI therapeutics company CombinAbleAI and launched its TherML platform, creating an end-to-end, ...
Business Wire

insitro Partners with Lilly to Build First-in-Kind Machine Learning Models to Advance Small Molecule Drug Discovery

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
Nature

Limited experimental data? No problem: Machine learning and physics in preclinical drug discovery

The rise of machine learning and accurate, physics-based modeling have facilitated breakthroughs in preclinical drug discovery, accelerating discovery of compounds with improved chemical properties at ...
EurekAlert!

Accelerating drug combination discovery with machine learning

(L) First and co-corresponding author Charlie Wright, PhD, St. and (R) co-corresponding author Paul Geeleher, PhD, both of the St. Jude Department of Computational Biology. (MEMPHIS, Tenn. – December ...